Salipro to present at a GPCR drug discovery workshop

Written By Lorena Galan

Join us at the upcoming GPCR drug discovery workshop on March 31 in Gothenburg, co-organized by InSingulo and Arjen Snijder from AstraZeneca! 

Our CEO, Jens Frauenfeld, will be presenting the latest developments on the Salipro® platform for GPCRs. At this event we'll explore the latest advancements in affinity screening, biophysical mode of action studies, hit finding, and structure-based drug discovery for these challenging drug targets. We look forward to joining experts from the field and discussing innovative solutions for drug discovery for GPCRs.


Lorena Galan
Previous

Salipro Biotech publishes research in Scientific Reports on structure-function studies for membrane proteins in collaboration with AstraZeneca
Next

Invited speaker at Oxford Global Biologics